Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 24, 2007Expert Opinion on Investigational Drugs

Liraglutide: a once-daily GLP-1 analogue for the treatment of Type 2 diabetes mellitus

View Full Paper
Ask AI
Bookmark
Share

Authors

TVTina VilsbøllUniversity of Copenhagen

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Tina Vilsbøll (2007) studied this question.

synapsesocial.com/papers/6a701f5b75498292b7097fc0https://doi.org/10.1517/13543784.16.2.231
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Rapid Gastric Emptying of a Solid Pancake Meal in Type II Diabetic Patients1996 · 118 citations
  2. 2Both Subcutaneously and Intravenously Administered Glucagon-Like Peptide I Are Rapidly Degraded From the NH2-Terminus in Type II Diabetic Patients and in Healthy Subjects1995 · 669 citations
  3. 3Distribution of GLP‐1 Binding Sites in the Rat Brain: Evidence that Exendin‐4 is a Ligand of Brain GLP‐1 Binding Sites1995 · 475 citations
  4. 4Exenatide versus Insulin Glargine in Patients with Suboptimally Controlled Type 2 Diabetes2005 · 796 citations
  5. 5Effect of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin as Monotherapy on Glycemic Control in Patients With Type 2 Diabetes2006 · 881 citations